The molecular mechanisms of regulatory T cell immunosuppression

Frontiers in Immunology

Volumn 2, Issue NOV, 2011, Pages

  Pandiyan, Pushpa ^a   Zheng, Lixin ^a   Lenardo, Michael J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Apoptosis; BIM cytokine deprivation death; Cytokine consumption; Foxp3; Immune suppression mechanism; Regulatory T cells; Th17; Tregs

Indexed keywords

EID: 84874122539     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2011.00060     Document Type: Review

References (117)

1. Anderson, C. C., and Chan, W. F. (2004). Mechanisms and models of peripheral CD4 T cell self-tolerance. Front. Biosci. 9, 2947-2963.
2. Anderson, M. S., Venanzi, E. S., Chen, Z., Berzins, S. P., Benoist, C., and Mathis, D. (2005). The cellular mechanism of Aire control of T cell tolerance. Immunity 23, 227-239.
3. Andersson, J., Tran, D. Q., Pesu, M., Davidson, T. S., Ramsey, H., O'Shea, J. J., and Shevach, E. M. (2008). CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGFbeta-dependent manner. J. Exp. Med. 205, 1975-1981.
4. Arnold, B., Schonrich, G., and Hammerling, G. J. (1993). Multiple levels of peripheral tolerance. Immunol. Today 14, 12-14.
5. Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., and Cantor, H. (2000). Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287, 860-864.
6. Bardel, E., Larousserie, F., Charlot-Rabiega, P., Coulomb-L'Hermine, A., and Devergne, O. (2008). Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J. Immunol. 181, 6898-6905.
7. Barthlott, T., Kassiotis, G., and Stockinger, B. (2003). T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197, 451-460.
8. Bending, D., Newland, S., Krejci, A., Phillips, J. M., Bray, S., and Cooke, A. (2011). Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J. Immunol. 186, 3373-3382.
9. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., and Ochs, H. D. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21.
10. Ben-Sasson, S. Z., Le Gros, G., Conrad, D. H., Finkelman, F. D., and Paul, W. E. (1990). IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J. Immunol. 145, 1127-1136.
11. Bettelli, E., Korn, T., and Kuchroo, V. K. (2007). Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19, 652-657.
12. Bidere, N., Su, H. C., and Lenardo, M. J. (2006). Genetic disorders of programmed cell death in the immune system. Annu. Rev. Immunol. 24, 321-352.
13. Bluestone, J. A., Mackay, C. R., O'Shea, J. J., and Stockinger, B. (2009). The functional plasticity of T cell subsets. Nat. Rev. Immunol. 9, 811-816.
14. Bonomo, A., Kehn, P. J., and Shevach, E. M. (1995). Post-thymectomy autoimmunity: abnormal T-cell homeostasis. Immunol. Today 16, 61-67.
15. Busse, D., De La Rosa, M., Hobiger, K., Thurley, K., Flossdorf, M., Scheffold, A., and Hofer, T. (2010). Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proc. Natl. Acad. Sci. U.S.A. 107, 3058-3063.
16. Chaturvedi, V., Collison, L. W., Guy, C. S., Workman, C. J., and Vignali, D. A. (2011). Cutting edge: human regulatory T cells require IL35 to mediate suppression and infectious tolerance. J. Immunol. 186, 6661-6666.
17. Chen, Y., Haines, C. J., Gutcher, I., Hochweller, K., Blumenschein, W. M., Mcclanahan, T., Hammerling, G., Li, M. O., Cua, D. J., and Mcgeachy, M. J. (2011). Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34, 409-421.
18. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V. K., and Weiner, H. L. (1995). Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177-180.
19. Collison, L. W., Chaturvedi, V., Henderson, A. L., Giacomin, P. R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C. J., Brown, S. A., Rehg, J. E., Jones, M. L., Ni, H. T., Artis, D., Turk, M. J., and Vignali, D. A. (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101.
20. Costantino, C. M., Baecher-Allan, C. M., and Hafler, D.A. (2008). Human regulatory T cells and autoimmunity. Eur. J. Immunol. 38, 921-924.
21. Coutinho, A., and Carneiro-Sampaio, M. (2008). Primary immunodeficiencies unravel critical aspects of the pathophysiology of autoimmunity and of the genetics of autoimmune disease. J. Clin. Immunol. 28(Suppl. 1), S4-S10.
22. Damle, N. K. (1986). Suppressor T lymphocytes in man. Facts and views. Year Immunol. 2, 60-67.
23. De La Rosa, M., Rutz, S., Dorninger, H., and Scheffold, A. (2004). Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2480-2488.
24. Dokmeci, E., Xu, L., Robinson, E., Golubets, K., Bottomly, K., and Herrick, C. A. (2011). EBI3 deficiency leads to diminished T helper type 1 and increased T helper type 2 mediated airway inflammation. Immunology 132, 559-566.
25. Esquerre, M., Tauzin, B., Guiraud, M., Muller, S., Saoudi, A., and Valitutti, S. (2008). Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-beta-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 105, 2550-2555.
26. Fontenot, J. D., and Rudensky, A. Y. (2005). A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331-337.
27. Gershon, R. K., and Kondo, K. (1971). Infectious immunological tolerance. Immunology 21, 903-914.
28. Glimcher, L. H., and Murphy, K. M. (2000). Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14, 1693-1711.
29. Hegazy, A. N., Peine, M., Helmstetter, C., Panse, I., Frohlich, A., Bergthaler, A., Flatz, L., Pinschewer, D. D., Radbruch, A., and Lohning, M. (2010). Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32, 116-128.
30. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Bouillet, P., Strasser, A., Kappler, J., and Marrack, P. (2002). Activated T cell death in vivo mediated by proapoptotic bcl-2 family member BIM. Immunity 16, 759-767.
31. Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., Garefalaki, A., Potocnik, A. J., and Stockinger, B. (2011). Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263.
32. Hofer, T., Nathansen, H., Lohning, M., Radbruch, A., and Heinrich, R. (2002). GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model. Proc. Natl. Acad. Sci. U.S.A. 99, 9364-9368.
33. Hoffmann, P., Boeld, T. J., Eder, R., Huehn, J., Floess, S., Wieczorek, G., Olek, S., Dietmaier, W., Andreesen, R., and Edinger, M. (2009). Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur. J. Immunol. 39, 1088-1097.
34. Hornung, F., Zheng, L., and Lenardo, M. J. (1997). Maintenance of clonotype specificity in CD95/Apo1/Fas-mediated apoptosis of mature T lymphocytes. J. Immunol. 159, 3816-3822.
35. Houde, N., Chamoux, E., Bisson, M., and Roux, S. (2009). TGF-{beta}1 induces human osteoclast apoptosis by uregulating bim. J. Biol. Chem. 284, 23397-233404.
36. Huehn, J., Polansky, J. K., and Hamann, A. (2009). Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 9, 83-89.
37. Janeway, C. A. Jr., Koren, H. S., and Paul, W. E. (1975). The role of thymus-derived lymphocytes in an antibody-mediated hapten-specific helper effect. Eur. J. Immunol. 5, 17-22.
38. Kearley, J., Barker, J. E., Robinson, D. S., and Lloyd, C. M. (2005). Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 202, 1539-1547.
39. Klein, L., Khazaie, K., and Von Boehmer, H. (2003). In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. U.S.A. 100, 8886-8891.
40. Komatsu, N., Mariotti-Ferrandiz, M. E., Wang, Y., Malissen, B., Waldmann, H., and Hori, S. (2009). Heterogeneity of natural Foxp3+ T cells: a committed regulatory Tcell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. U.S.A. 106, 1903-1908.
41. Korn, T., Anderson, A. C., Bettelli, E., and Oukka, M. (2007). The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J. Neuroimmunol. 191, 51-60.
42. Kyewski, B., and Klein, L. (2006). A central role for central tolerance. Annu. Rev. Immunol. 24, 571-606.
43. Lahl, K., Mayer, C. T., Bopp, T., Huehn, J., Loddenkemper, C., Eberl, G., Wirnsberger, G., Dornmair, K., Geffers, R., Schmitt, E., Buer, J., and Sparwasser, T. (2009). Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J. Immunol. 183, 5662-5672.
44. Lanteri, M. C., O'Brien, K. M., Purtha, W. E., Cameron, M. J., Lund, J. M., Owen, R. E., Heitman, J. W., Custer, B., Hirschkorn, D. F., Tobler, L. H., Kiely, N., Prince, H. E., Ndhlovu, L. C., Nixon, D. F., Kamel, H. T., Kelvin, D. J., Busch, M. P., Rudensky, A. Y., Diamond, M. S., and Norris, P. J. (2009). Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 119, 3266-3277.
45. Le Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., and Paul, W. E. (1990). Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4producing cells. J. Exp. Med. 172, 921-929.
46. Lenardo, M. J. (1991). Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858-861.
47. Lenardo, M., Chan, K. M., Hornung, F., Mcfarland, H., Siegel, R., Wang, J., and Zheng, L. (1999). Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253.
48. Liu, F., Tong, F., He, Y., and Liu, H. (2011). Detectable expression of IL35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin. Immunol. 139, 1-5.
49. Lohr, J., Knoechel, B., Caretto, D., and Abbas, A. K. (2009). Balance of Th1 and Th17 effector and peripheral regulatory T cells. Microbes Infect. 11, 589-593.
50. Maloy, K. J., and Powrie, F. (2005). Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat. Immunol. 6, 1071-1072.
51. Miller, J. F., and Morahan, G. (1992). Peripheral T cell tolerance. Annu. Rev. Immunol. 10, 51-69.
52. Moraes-Vasconcelos, D., Costa-Carvalho, B. T., Torgerson, T. R., and Ochs, H. D. (2008). Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J. Clin. Immunol. 28(Suppl. 1), S11-S19.
53. Mosmann, T. R., and Coffman, R. L. (1989a). Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46, 111-147.
54. Mosmann, T. R., and Coffman, R. L. (1989b). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
55. Oberle, N., Eberhardt, N., Falk, C. S., Krammer, P. H., and Suri-Payer, E. (2007). Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J. Immunol. 179, 3578-3587.
56. Ouyang, W., Lohning, M., Gao, Z., Assenmacher, M., Ranganath, S., Radbruch, A., and Murphy, K. M. (2000). Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 12, 27-37.
57. Pandiyan, P., Conti, H. R., Zheng, L., Peterson, A. C., Mathern, D. R., Hernandez-Santos, N., Edgerton, M., Gaffen, S. L., and Lenardo, M. J. (2011). CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34, 422-434.
58. Pandiyan, P., Gartner, D., Soezeri, O., Radbruch, A., Schulze-Osthoff, K., and Brunner-Weinzierl, M. C. (2004). CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activationinduced cell death by a mechanism requiring PI3 kinase function. J. Exp. Med. 199, 831-842.
59. Pandiyan, P., and Lenardo, M. J. (2008). The control of CD4+CD25+Foxp3+ regulatory T cell survival. Biol. Direct 3, 6.
60. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., and Lenardo, M. J. (2007). CD4(+)CD25(+)Foxp3(+) regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4(+) T cells. Nat. Immunol. 8, 1353-1362.
61. Pasare, C., and Medzhitov, R. (2003). Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033-1036.
62. Paul, W. E., and Seder, R. A. (1994). Lymphocyte responses and cytokines. Cell 76, 241-251.
63. Powrie, F., Leach, M. W., Mauze, S., Menon, S., Caddle, L. B., and Coffman, R. L. (1994). Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1, 553-562.
64. Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., Hou, T. Z., Futter, C. E., Anderson, G., Walker, L. S., and Sansom, D. M. (2011). Transendocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603.
65. Ramesh, S., Qi, X. J., Wildey, G. M., Robinson, J., Molkentin, J., Letterio, J., and Howe, P. H. (2008). TGF betamediated BIM expression and apoptosis are regulated through SMAD3dependent expression of the MAPK phosphatase MKP2. EMBO Rep. 9, 990-997.
66. Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., and Rudensky, A. Y. (2010). Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671.
67. Rubtsov, Y. P., Rasmussen, J. P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R. Jr., Muller, W., and Rudensky, A. Y. (2008). Regulatory T cellderived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558.
68. Rudensky, A. Y., and Campbell, D. J. (2006). In vivo sites and cellular mechanisms of T reg cellmediated suppression. J. Exp. Med. 203, 489-492.
69. Sakaguchi, S., Takahashi, T., and Nishizuka, Y. (1982). Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156, 1577-1586.
70. Sakaguchi, S., Toda, M., Asano, M., Itoh, M., Morse, S. S., and Sakaguchi, N. (1996). T cell-mediated maintenance of natural selftolerance: its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun. 9, 211-220.
71. Sakaguchi, S., and Wing, K. (2011). Immunology. Damping by depletion. Science 332, 542-543.
72. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P., and Yamaguchi, T. (2009). Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105-1111.
73. Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008). Regulatory T cells and immune tolerance. Cell 133, 775-787.
74. Sanjabi, S., Mosaheb, M. M., and Flavell, R. A. (2009). Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells. Immunity 31, 131-144.
75. Scheffold, A., Huhn, J., and Hofer, T. (2005). Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL)two to tango. Eur. J. Immunol. 35, 1336-1341.
76. Schimpl, A., Berberich, I., Kneitz, B., Kramer, S., Santner-Nanan, B., Wagner, S., Wolf, M., and Hunig, T. (2002). IL-2 and autoimmune disease. Cytokine Growth Factor Rev. 13, 369-378.
77. Schwartz, R. H. (2003). T cell anergy. Annu. Rev. Immunol. 21, 305-334.
78. Seder, R. A., and Paul, W. E. (1994). Acquisition of lymphokineproducing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12, 635-673.
79. Shevach, E. M. (2011). The resurrection of T cell-mediated suppression. J. Immunol. 186, 3805-3807.
80. Shevach, E. M. (2002). CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400.
81. Shevach, E. M., Mchugh, R. S., Piccirillo, C. A., and Thornton, A. M. (2001). Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182, 58-67.
82. Shevach, E. M., Tran, D. Q., Davidson, T. S., and Andersson, J. (2008). The critical contribution of TGFbeta to the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38, 915-917.
83. Sprent, J. (1995). Central tolerance of T cells. Int. Rev. Immunol. 13, 95-105.
84. Sprent, J., and Surh, C. D. (2001). Generation and maintenance of memoryTcells. Curr. Opin. Immunol. 13, 248-254.
85. St Clair, E. W., Turka, L. A., Saxon, A., Matthews, J. B., Sayegh, M. H., Eisenbarth, G. S., and Bluestone, J. (2007). New reagents on the horizon for immune tolerance. Annu. Rev. Med. 58, 329-346.
86. Stockinger, B. (1999). T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv. Immunol. 71, 229-265.
87. Strasser, A. (2005). The role of BH3only proteins in the immune system. Nat. Rev. Immunol. 5, 189-200.
88. Strasser, A., Puthalakath, H., Bouillet, P., Huang, D. C., O'Connor, L., O'Reilly, L. A., Cullen, L., Cory, S., and Adams, J. M. (2000). The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in celldeath control. Ann. N. Y. Acad. Sci. 917, 541-548.
89. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., and Glimcher, L. H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669.
90. Tadokoro, C. E., Shakhar, G., Shen, S., Ding, Y., Lino, A. C., Maraver, A., Lafaille, J. J., and Dustin, M. L. (2006). Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203, 505-511.
91. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., and Sakaguchi, S. (1998). Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980.
92. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., and Sakaguchi, S. (2000). Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
93. Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaria, P., Locksley, R. M., Krummel, M. F., and Bluestone, J. A. (2006). Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7, 83-92.
94. Tang, Q., and Bluestone, J. A. (2008). The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239-244.
95. Thornton, A. M., Donovan, E. E., Piccirillo, C. A., and Shevach, E. M. (2004a). Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172, 6519-6523.
96. Thornton, A. M., Piccirillo, C. A., and Shevach, E. M. (2004b). Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur. J. Immunol. 34, 366-376.
97. Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., and Shevach, E. M. (2010). Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from periph-erally induced Foxp3+ Tregulatory cells. J. Immunol. 184, 3433-3441.
98. Thornton, A. M., and Shevach, E. M. (1998). CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296.
99. Thornton, A. M., and Shevach, E. M. (2000). Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183-190.
100. Tinoco, R., Alcalde, V., Yang, Y., Sauer, K., and Zuniga, E. I. (2009). Cell-intrinsic transforming growth factor-beta signaling mediates virusspecific CD8+ T cell deletion and viral persistence in vivo. Immunity 31, 145-157.
101. Tran, D. Q., Andersson, J., Wang, R., Ramsey, H., Unutmaz, D., and Shevach, E. M. (2009a). GARP (LRRC32) is essential for the surface expression of latent TGF-{beta} on platelets and activated FOXP3+ regulatory T cells. J. Immunol. 182, 2929-2938.
102. Tran, D. Q., Glass, D. D., Uzel, G., Darnell, D. A., Spalding, C., Holland, S. M., and Shevach, E. M. (2009b). Analysis of adhesion molecules, target cells, and role of IL2 in human FOXP3+ regulatory T cell suppressor function. J. Immunol. 182, 2929-2938.
103. Tykocinski, L. O., Hajkova, P., Chang, H. D., Stamm, T., Sozeri, O., Lohning, M., Hu-Li, J., Niesner, U., Kreher, S., Friedrich, B., Pannetier, C., Grutz, G., Walter, J., Paul, W. E., and Radbruch, A. (2005). A critical control element for interleukin-4 memory expression in T helper lymphocytes. J. Biol. Chem. 280, 28177-28185.
104. Von Boehmer, H. (2005). Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338-344.
105. Wan, Y. Y., and Flavell, R. A. (2007). 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol. Rev. 220, 199-213.
106. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., and Sakaguchi, S. (2008). CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275.
107. Wing, K., Yamaguchi, T., and Sakaguchi, S. (2011). Cell-autonomous and non-autonomous roles of CTLA4 in immune regulation. Trends Immunol. 32, 428-433.
108. Yagi, R., Junttila, I. S., Wei, G., Urban, J. F. Jr., Zhao, K., Paul, W. E., and Zhu, J. (2010). The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity 32, 507-517.
109. Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B., Chang, S. H., Schluns, K. S., Watowich, S. S., Feng, X. H., Jetten, A. M., and Dong, C. (2008). Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56.
110. Zheng, X. X., Sanchez-Fueyo, A., Domenig, C., and Strom, T. B. (2003). The balance of deletion and regulation in allograft tolerance. Immunol. Rev. 196, 75-84.
111. Zhou, X., Bailey-Bucktrout, S., Jeker, L. T., and Bluestone, J. A. (2009a). Plasticity of CD4(+) FoxP3(+)T cells. Curr. Opin. Immunol. 21, 281-285.
112. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., and Bluestone, J. A. (2009b). Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.
113. Zhou, Y. (2008). Regulatory T cells and viral infections. Front. Biosci. 13, 1152-1170.
114. Zhou, Z., Song, X., Li, B., and Greene, M. I. (2008). FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity. Immunol. Res. 42, 19-28.
115. Zhu, J., and Paul, W. E. (2010). Heterogeneity and plasticity of T helper cells. Cell Res. 20, 4-12.
116. Zhu, P., Jiang, W., Cao, L., Yu, W., Pei, Y., Yang, X., Wan, B., Liu, J. O., Yi, Q., and Yu, L. (2010). IL-2 mRNA stabilization upon PMA stimulation is dependent on NF90-Ser647 phosphorylation by protein kinase CbetaI. J. Immunol. 185, 5140-5149.
117. Zorro Manrique, S., Duque Correa, M. A., Hoelzinger, D. B., Dominguez, A. L., Mirza, N., Lin, H. H., SteinStreilein, J., Gordon, S., and Lustgarten, J. (2011). Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth. J. Exp. Med. 208, 1485-1499.